,i #aaith ,,congress #b;d ,session ,h4 ,r4 #iifi ,,in ,,the ,,house ,,of ,,representatives ,july #bg1 #bjbf,mr4 ,pappas 7for himself and ,ms4 ,de,lauro7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to direct the ,federal ,trade ,commission to conduct an investigation and submit to ,congress a report on unfair or deceptive acts or practices that may be prevalent in the advertising or marketing of preterm infant formula and to issue regulations to prohibit unfair or deceptive acts or practices related to the advertising or marketing of preterm infant formula1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,baby ,brent's ,bill4 #b4 ,sense of ,congress ,it is the sense of ,congress that-- 7#a7 parents should retain the right to be fully informed about1 and to take steps to protect1 the health of their preterm infants2 7#b7 there are numerous studies that document that1 when necessary1 human milk-based fortifiers are generally considered safer than bovine fortifiers2 7#c7 scientific gaps still exist for better understanding how certain feeding practices may impact a preterm infant developing necrotizing enterocolitis 7in this section referred to as ,,nec72 7#d7 one of the deadliest comorbidities associated with prematurity and the most common gastrointestinal emergency experienced by preterm infants in the ,newborn ,intensive ,care ,unit is ,,nec2 7#e7 #a baby dies of ,,nec each day2 7#f7 strong individual protection for preterm infants and their families is critical to preserving their ability to seek compensation when harm occurs1 specifically in cases where preterm infants were exposed to factors that may have increased the risk of developing ,,nec2 and 7#g7 no manufacturer of preterm infant formula or related products should be permitted to limit1 evade1 or otherwise diminish the ability of families to pursue legal recourse when their preterm infants experience harm4 #c4 ,unfair or deceptive acts or practices related to the advertising and marketing of preterm infant formula 7a7 ,investigation and report by ,commission 7#a7 ,investigation 7,a7 ,in general ,the ,commission shall conduct an investigation on the advertising and marketing of preterm infant formula that shall identify potentially unfair or deceptive acts or practices that may be prevalent in such advertising or marketing1 as well as any other information as the ,commission determines appropriate4 7,b7 ,considerations ,in conducting the investigation required by subparagraph 7,a71 the ,commission shall consider advertising or marketing materials with respect to preterm infant formula that may exclude-- 7i7 labeling information about potential health risks associated with the consumption of preterm infant formula and fortifiers2 or 7ii7 differences1 including with respect to benefits and drawbacks1 between consuming human breast milk and human milk-based fortifiers and consuming bovine-based fortifiers during infancy4 7#b7 ,report ,not later than #a year after the date of the enactment of this section1 the ,commission shall submit to ,congress a report on the investigation required by paragraph 7#a77;,a7 and any recommendation for legislation or administrative action as the ,commission determines appropriate4 7#c7 ,exemption from ,paperwork ,reduction ,act ,this subsection is exempt from subchapter ,i of chapter #ce of title #dd1 ,united ,states ,code 7commonly known as the ,paperwork ,reduction ,act74 7b7 ,regulations 7#a7 ,in general ,not later than #ah months after the date on which the ,commission submits the report as required by subsection 7a77#b71 the ,commission shall promulgate1 under section #eec of title #e1 ,united ,states ,code1 regulations to prohibit any manufacturer or importer of preterm infant formula from engaging in any unfair or deceptive act or practice related to the advertising or marketing of preterm infant formula4 7#b7 ,requirements ,in promulgating regulations pursuant to paragraph 7#a71 the ,commission shall address advertising or marketing materials with respect to preterm infant formula that may exclude-- 7,a7 labeling information about potential health risks associated with the consumption of preterm infant formula and fortifiers2 or 7,b7 differences1 including with respect to benefits and drawbacks1 between consuming human breast milk and human milk-based fortifiers and consuming bovine-based fortifiers during infancy4 7c7 ,enforcement 7#a7 ,unfair or deceptive acts or practices ,a violation of a regulation promulgated pursuant to subsection 7b77#a7 shall be treated as a violation of a rule defining an unfair or deceptive act or practice under section #ah7;a77#a77;,b7 of the ,federal ,trade ,commission ,act 7#ae ,u4,s4,c4 #eg;a7a77#a77;,b774 7#b7 ,powers of ,commission 7,a7 ,in general ,the ,commission shall enforce the regulations promulgated pursuant to subsection 7b77#a7 in the same manner1 by the same means1 and with the same jurisdiction1 powers1 and duties as though all applicable terms and provisions of the ,federal ,trade ,commission ,act 7#ae ,u4,s4,c4 #da et seq47 were incorporated into and made a part of this ,act4 7,b7 ,privileges and immunities ,any person who violates a regulation promulgated pursuant to subsection 7b77#a7 shall be subject to the penalties and entitled to the privileges and immunities provided in the ,federal ,trade ,commission ,act 7#ae ,u4,s4,c4 #da et seq474 7d7 ,definitions ,in this section3 7#a7 ,commission ,the term ,commission means the ,federal ,trade ,commission4 7#b7 ,preterm infant ,the term preterm infant means an infant who-- 7,a7 is born before #cg weeks of gestation2 or 7,b7 is a low birth weight infant4 7#c7 ,preterm infant formula ,the term preterm infant formula means any infant formula that-- 7,a7 is exempt under section #dab7;h77#a7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cej;a7h77#a772 and 7,b7 is intended to be administered to a preterm infant4